ActiMaris AG

Studien

Detaillierte Studien und Laborberichte können Sie auf Anfrage von uns verlangen.

Publizierte Studien mit ActiMaris Produkten:

1. ORL-Studie
   ActiMaris klinische ORL-Studie bei entzündlichen Haut- und Schleimhautprozessen
2. Studie mit Akne
   Klinische Anwendungsbeobachtung eines Meersalz-Sauerstoffkomplexes für die lokale Applikation
3. JWC-Studie: Prontosan vs ActiMaris
   A clinical evalutation of the efficacy and safety of singlet oxygen in cleansing and disinfecting stagnating wounds
4. Witten-Studie (in vitro Studie mit 6 HOCl/NaOCl Wundprodukten)
   Safety and efficacy profiles of different commercial sodium hypochlorite/hypochlorous acid solutions (NaClO/HClO): antimicrobial efficacy, cytotoxic impact and physicochemical parameters in vitro
5. Antimikrobielle in vivo Studie
   Use of wet-to-moist cleansing nwith different irrigation solutions to reduce bacterial bioburden in chronic wounds
6. Interessante Erkenntnisse
   Restrospektive Studienumfrage zu modernen Wundspüllösungen des HOCl / NaOCl-Typs in der täglichen Wundpraxis
7. Neue Perspektive eines alten Naturkonzepts
   Das Geheimnis des Rosetta-Steins, REDOX Code und die Rolle der HOCl/NaOCl Hybrid-Lösungen (Datenanalyse) in der lokalen Therapie der chronischen Wunden
8. Advantages of negative pressure wound therapy
   Advantages of negative pressure wound therapy with instillation of super oxidized solution and dwell time in diabetic foot syndrome: a rare case report
9. Antimicrobial Efficacy of FiveWound Irrigation Solutions in the Periprosthetic Joint InfectionMicroenvironment In Vitro and Ex Vivo
10. Moderne Wundspüllösungen auf dem Prüfstand für die Praxis
    Eine Follow-up Studie zur Gegenprüfung in vitro zu vorhandenen in vivo-Daten
11. Kritisch kolonisierte und ortsständig infizierte Wunden (pro care 9-2015 – G. Kammerlander et. al.)
12. Nass/Trockenphase 3.0 (clinicum 6-24 – G. Kammerlander et. al.)
13. Moderne Wundspüllösungen und silberhaltige Wundprodukte (pro care 5-2020 – G. Kammerlander et. al.)
14. Bewertung der biofilmabtötenden Wirkung verschiedener antimikrobieller Lösungen (IIS La Fe, Palex 2025)
15. Does the in vitro efficacy promise correlate with the in vivo reality and clinical effectiveness in the local wound treatment with antimicrobials? (Abu Dhabi wound care conference 4-2025; a review)
16. Antimicrobial efficacy, cytotoxic impect and physico-chemical parameters of HOCl/NaOCl solution used in wund care: an in vitro study. (Int. Wound Journal 2018)
17. Effetto di Actimaris forte in un modello di infezione da S. aureus MRSA indotta in vitro su frammenti di osso sintetico (Rom/I, 2025)
18. Testing the microbicidal efficacy and security of ActiMaris (National Institute of Public Health (SZÚ), Prague CZ)
19. Confarma Laboratory Test

Aktuell laufen vier klinische randomisierte komparative Studien mit ActiMaris Produkten:

1. Bioflush – Removal of intestinal biofilms to reduce IBS symptoms, an exploratory randomized, controlled, observer-subject-blinded study.
   (ActiMaris SENSITIVE wound irrigation solution vs. Placebo)
2. Vergleichende Untersuchung zweier Lokaltherapie-Konzepte
   (ActiMaris SENSITIVE Wundspüllösung und ActiMaris Wundgel vs. Microdacyn Wundspüllösung und Microdacyn Gel)
3. Utilizzo di antisettici per il trattamento della gengivite in età pediatrica.
   (ActiMaris FORTE vs. clorexidina 0.12%)
4. ActiMaris effectiveness in the evaluation of the ability of sodium hypochlorite solution in bacterial eradication from conteminated cancellus bone.
   Preliminary results show a dramatical reduction in bacterial growth on culture bases, even for the short period of contact between ActiMaris FORTE wound irrigation solution and cancellous bone (with an almost complete absence of growth after 4 minutes.)
5. John Hopkins Evidence-Based Practice Model for Nursing and Healthgare Professionals.
   What is the best practice in improving the healing process of wound among ICU adults and geriatric patients?
   Decubitus / Pressure injury therapy concept with ActiMaris products at the geriatric clinic.
   Emirates Health Services (EHS Dubai) / EBP team. Maitha Ebrahim / Dr. Rania & Ms. Hanane Egli (ActiMaris representative) Goal comletion date: 2nd to 3rd Quarter 2023

Geplante Studien mit ActiMaris Produkten:

1. The USE of ActiMaris Solution and Gel in the Prevention and Treatment of Periodontal Diseases
2. The USE of ActiMaris Solution and Gel during Endodontic Treatment
3. ActiMaris Solution vs. Comparator(s) for Thoracic and Abdominal Lavage during/after Surgery for differnt Infaction Processes and Peritonitis.

Schreiben Sie uns ein E-Mail füllen Sie folgendes Kontaktformular aus.